CVS logo

CVS Health Corporation Stock Price

NYSE:CVS Community·US$122.4b Market Cap
  • 3 Narratives written by author
  • 10 Comments on narratives written by author
  • 482 Fair Values set on narratives written by author

CVS Share Price Performance

US$95.70
30.82 (47.50%)
US$104.01
Fair Value
US$95.70
30.82 (47.50%)
8.0% undervalued intrinsic discount
US$104.01
Fair Value
Price US$95.70
yiannisz US$104.01
AnalystConsensusTarget US$114.88
julio US$62.09

CVS Community Narratives

Fair Value
·
Fair Value US$104.01 8.0% undervalued intrinsic discount

Why CVS’s Valuation Signals Opportunity

13users have liked this narrative
9users have commented on this narrative
111users have followed this narrative
·
Fair Value US$114.88 16.7% undervalued intrinsic discount

Managed Care Margin Recovery And Healthcare Benefits Will Shape Industry Prospects

1users have liked this narrative
1users have commented on this narrative
201users have followed this narrative
Fair Value
·
Fair Value US$62.09 54.1% overvalued intrinsic discount

CVS VALUATION

1users have liked this narrative
0users have commented on this narrative
12users have followed this narrative
US$104.01
8.0% undervalued intrinsic discount
Fair Value
Revenue
18.02% p.a.
Profit Margin
1.99%
Future PE
9.88x
Price in 2029
US$144.91
US$62.09
54.1% overvalued intrinsic discount
Fair Value
Revenue
7% p.a.
Profit Margin
2.01%
Future PE
12x
Price in 2034
US$168.01

Updated Narratives

CVS logo

CVS Health: Rebuilding a Healthcare Giant From the Inside Out

Fair Value: US$104.01 8.0% undervalued intrinsic discount
111 users have set this as their fair value
9 users have commented on this narrative
0 users have liked this narrative
CVS logo

CVS VALUATION

Fair Value: US$62.09 54.1% overvalued intrinsic discount
12 users have set this as their fair value
0 users have commented on this narrative
0 users have liked this narrative
CVS logo

CVS: GLP 1 Expansion And Legal Risks Will Shape Future Earnings

Fair Value: US$114.88 16.7% undervalued intrinsic discount
201 users have set this as their fair value
1 users have commented on this narrative
0 users have liked this narrative

Snowflake Analysis

Undervalued established dividend payer.

2 Risks
4 Rewards

CVS Health Corporation Key Details

US$412.6b

Revenue

US$356.3b

Cost of Revenue

US$56.3b

Gross Profit

US$51.4b

Other Expenses

US$4.9b

Earnings

Last Reported Earnings
Jun 30, 2026
Next Reporting Earnings
n/a
3.82
13.64%
1.19%
76.9%
View Full Analysis

About CVS

Founded
1963
Employees
259500
CEO
J. Joyner
WebsiteView website
www.cvshealth.com

CVS Health Corporation provides health solutions in the United States. The Health Care Benefits segment offers traditional, voluntary, and consumer-directed health insurance products and related services, including medical, pharmacy, dental, and behavioral health plans; medical management capabilities; Medicare Advantage and Medicare Supplement plans; prescription drug plans (PDPs); and Medicaid health care management services. It serves employer groups, individuals, college students, part-time and hourly workers, health plans, health care providers, governmental units, government-sponsored plans, labor groups, and expatriates. The Health Services segment offers pharmacy benefit management solutions, including plan design and administration, formulary management, retail pharmacy network management, specialty and mail-order pharmacy, clinical services, disease management, medical spend management services, and pharmacy and other administrative services. It serves employers, insurance companies, unions, government employee groups, health plans, PDPs, Medicaid managed care plans, CMS, plans offered on public health insurance exchanges, and other sponsors of health benefit plans. The Pharmacy & Consumer Wellness segment sells prescription and over-the-counter drugs, consumer health and beauty products, personal care products, and other general merchandise products. This segment also distributes prescription drugs; and provides related pharmacy consulting and other ancillary services to care facilities and other care settings. It operates online retail pharmacy websites, retail specialty pharmacy stores, and compounding pharmacies, as well as branches for infusion and enteral nutrition services. The company was formerly known as CVS Caremark Corporation and changed its name to CVS Health Corporation in September 2014. CVS Health Corporation was founded in 1963 and is headquartered in Woonsocket, Rhode Island.

Recent CVS News & Updates

Seeking Alpha 4h

CVS Health: I Wanted A Beat And Raise, I Got It, And I'm Still At 'Hold'

Summary CVS Health Corporation's strong Q2 results delivered revenue and earnings beats while management raised operating cash flow guidance to $11.5 billion. Aetna turnaround and improved medical benefit ratios boosted first half cash generation, helping drive recent stock gains. Management anticipates higher second half medical costs alongside 2027 headwinds from 340B pricing and pharmacy drug mix shifts. Strengthening cash flow supports deleveraging and dividend safety, but the recent CVS stock rally keeps the thesis at Hold. Read the full article on Seeking Alpha
Narrative Update Aug 05

CVS: GLP 1 Expansion And Legal Risks Will Shape Future Earnings

The analyst price target for CVS Health has shifted from $111.92 to $114.88. This change reflects updated views from recent Street research that focuses on valuation, medical loss ratio trends, regulatory clarity, and ongoing growth investments across its healthcare services businesses.

Recent updates

No updates